Scarica l'app Stockscreener
2.93
1.74%
0.05
Pre-mercato:
2.85
-0.08
-2.73%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Anixa Biosciences Inc Borsa (ANIX) Ultime notizie
Anixa Biosciences Highlights Lean Cash Burn, CAR-T Survival Signals, and Phase II Vaccine Plan at Conference - Yahoo Finance
Weekly Trades: Does Anixa Biosciences Inc have declining or rising EPS2026 Reactions & Daily Profit Maximizing Tips - baoquankhu1.vn
Aug Macro: Can Anixa Biosciences Inc maintain its current growth rate2026 Analyst Calls & Consistent Profit Trade Alerts - baoquankhu1.vn
AVAX Technologies and Anixa Biosciences Compared in Critical Analysis - National Today
Earnings Risk: Does Anixa Biosciences Inc have declining or rising EPSWeekly Trend Recap & Daily Growth Stock Investment Tips - baoquankhu1.vn
Anixa Biosciences Reports Positive Clinical Trial Results for Cancer Vaccines - Intellectia AI
Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026 - Finviz
At April 16 event, Anixa will spotlight 74% immune response data - Stock Titan
Anixa Biosciences Price Target Maintained With a $10.00/Share by D. Boral Capital - Moomoo
ANIX Stock: Consistent 'Buy' Rating and Price Target Maintained - GuruFocus
Anixa Biosciences' (ANIX) "Buy" Rating Reiterated at D. Boral Capital - MarketBeat
Anixa Biosciences to Present at Water Tower Research Insights Conference - National Today
Anixa Biosciences to Participate in Water Tower Research Insights Conference on April 14, 2026 - PR Newswire
74% vaccine response, CAR-T survival data on Anixa's April 14 agenda - Stock Titan
Breast cancer vaccine hit Phase 1 goals; Anixa cites CAR-T survival data - Stock Titan
Anixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs - Barchart.com
Anixa Biosciences (NASDAQ:ANIX) Stock Rating Lowered by Wall Street Zen - MarketBeat
Anixa partners with Cytovance for breast cancer vaccine trial By Investing.com - Investing.com South Africa
ANIX Stock Price, Quote & Chart | ANIXA BIOSCIENCES INC (NASDAQ:ANIX) - ChartMill
Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing - Sahm
Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 - GuruFocus
Anixa Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results - Oncodaily
Eli Lilly, Space stocks, Anixa Biosciences - TradingView — Track All Markets
Anixa Biosciences (ANIX) Advances Breast Cancer Vaccine with New Manufacturing Agreement - GuruFocus
Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 with Selection of Cytovance Biologics for cGMP Manufacturing - irw-press.com
Anixa partners with Cytovance for breast cancer vaccine trial - Investing.com
Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results Cytovance Selected For Cgmp Manufacturing - TradingView
Anixa Biosciences, Inc. (ANIX) Stock Price, News, Quote & History - Yahoo Finance
ANIX: Anixa Biosciences Retains 'Buy' Rating with Price Target U - GuruFocus
Anixa Biosciences, Inc. (ANIX) Options Chain - Yahoo! Finance Canada
Anixa Biosciences (NASDAQ:ANIX) Given Buy Rating at D. Boral Capital - MarketBeat
Anixa Biosciences to Present Ovarian Cancer CAR-T Therapy Trial at Gynecologic Oncology Conference - National Today
Anixa Biosciences Advances Cancer Therapy with Lira-cel Trial Update - Intellectia AI
Doctors will get a Phase 1 update on Anixa's ovarian cancer CAR-T - Stock Titan
Anixa Biosciences announces that clinical trial results for its CAR-T therapy targeting ovarian cancer will be officially released at the Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer. - Bitget
Anixa Biosciences, Inc.Common Stock (NQ: ANIX - The Chronicle-Journal
Investment Review: Can Anixa Biosciences Inc keep up with sector leaders2026 Fed Impact & Stock Market Timing Techniques - baoquankhu1.vn
Earnings Recap: Whats the beta of Anixa Biosciences Inc stockPortfolio Performance Report & Technical Pattern Based Buy Signals - baoquankhu1.vn
We're Not Very Worried About Anixa Biosciences' (NASDAQ:ANIX) Cash Burn Rate - Sahm
Anixa Biosciences (NASDAQ:ANIX) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Exclusive: Anixa Biosciences' ovarian cancer drug candidate shows longer survival with no major safety issues - MSN
Anixa Biosciences (NASDAQ:ANIX) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Anixa Biosciences AGM: Shareholders Back Directors as CEO Highlights CAR-T, Vaccine Progress - MarketBeat
Can Anixa Biosciences Inc keep up with sector leadersTrade Risk Assessment & Verified Stock Trade Ideas - baoquankhu1.vn
Anixa Biosciences Featured on Water Tower Research Healthcare Ha - GuruFocus
Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast - PR Newswire
Experimental breast cancer vaccine shows positive data, Anixa CEO says - Stock Titan
Anixa Biosciences Shareholders Back Board and Compensation - TipRanks
Anixa Biosciences (NASDAQ: ANIX) investors approve directors, pay and auditor - Stock Titan
Anixa Biosciences Inc. Q1 2026 Financial Report: Earnings, Balance Sheet, and Key Disclosures - Minichart
2.69%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):